Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers

被引：4
|
作者：
Imai, Ryosuke [1 ]
Ikemura, Sumie [2 ]
Jinta, Torahiko [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, 9-1 Akashi Cho, Chuo City, Tokyo 1048560, Japan
[2] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan
来源：
RESPIROLOGY CASE REPORTS | 2021年 / 9卷 / 04期
关键词：
Dermatomyositis; durvalumab; immune checkpoint inhibitor; intravenous immunoglobulin;
D O I：
10.1002/rcr2.736
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We report a case of anti-transcriptional intermediary factor 1 gamma (TIF1 gamma) antibody-positive dermatomyositis following durvalumab treatment. The patient was successfully treated with pulse steroid therapy, high-dose intravenous immunoglobulin (IVIg), and tacrolimus. Durvalumab may induce dermatomyositis, and early diagnosis and aggressive therapy are crucial to prevent severe dermatomyositis, which is potentially treatable.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
    Sakurai, Takuya
    Takahashi, Junichiro
    Komatsu, Teppei
    Mitsumura, Hidetaka
    Iguchi, Yasuyuki
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (02) : 416 - 421
  • [2] Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
    Kotobuki, Yorihisa
    Tonomura, Kyoko
    Fujimoto, Manabu
    IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 23 - 29
  • [3] Anti-TIF1-γ antibody-positive dermatomyositis
    Li, Chia-Lun
    Ma, Sheng-Hsiang
    Wu, Chen-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2583 - 2584
  • [4] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [5] Amyopathic anti-TIF1-γ antibody-positive dermatomyositis in a young man
    Kluger, Nicolas
    JEADV CLINICAL PRACTICE, 2024, 3 (03): : 891 - 894
  • [6] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
    Lerman, Irina
    Richardson, Christopher T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [7] Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies
    Muro, Yoshinao
    Ishikawa, Asuka
    Sugiura, Kazumitsu
    Akiyama, Masashi
    RHEUMATOLOGY, 2012, 51 (08) : 1508 - 1513
  • [8] Dermatomyositis with positive anti-TIF1 gamma antibodies in an adult female: A case report
    Adhikari, Krishna
    Pant, Prashant
    Bhandari, Sanjeev
    Paudel, Sandip
    Poudyal, Buddhi
    Sharma, Lucky
    Sigdel, Keshav Raj
    Subedi, Rojina
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [9] Effectiveness of IVIG and balloon dilation combination therapy for refractory dysphagia in anti-TIF1-gamma antibody-positive dermatomyositis
    Utsunomiya, Akira
    Koizumi, Haruka
    Iino, Shiro
    Takashima, Wataru
    Tokuriki, Atsushi
    Tokunaga, Takahiro
    Kobayashi, Namiko
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    MODERN RHEUMATOLOGY CASE REPORTS, 2018, 2 (01) : 49 - 53
  • [10] Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma
    Otsuki, Takuya
    Ishizuka, Kosuke
    Eto, Hiromitsu
    Nakano, Hiroyasu
    Kato, Yo
    Sudo, Hiroshi
    Motohashi, Iori
    Ie, Kenya
    Ohira, Yoshiyuki
    Okuse, Chiaki
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1932 - 1936
12345